Filing Details

Accession Number:
0000937556-19-000046
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-02-27 16:56:04
Reporting Period:
2019-02-25
Accepted Time:
2019-02-27 16:56:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
937556 Masimo Corp MASI Electromedical & Electrotherapeutic Apparatus (3845) 330368882
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1442689 Jon Coleman C/O Masimo Corporation
52 Discovery
Irvine CA 92618
Pres-Ww Sales,Pro Svc,Med Affs No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-02-25 2,000 $31.01 13,201 No 4 M Direct
Common Stock Disposition 2019-02-25 2,000 $130.00 11,201 No 4 S Direct
Common Stock Acquisiton 2019-02-27 2,000 $31.01 13,201 No 4 M Direct
Common Stock Disposition 2019-02-27 2,000 $135.00 11,201 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (Right to Buy) Disposition 2019-02-25 2,000 $31.01 2,000 $31.01
Common Stock Non-Qualified Stock Option (Right to Buy) Disposition 2019-02-27 2,000 $31.01 2,000 $31.01
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
16,000 2016-03-20 2025-03-20 No 4 M Direct
14,000 2016-03-20 2025-03-20 No 4 M Direct
Footnotes
  1. The shares covered by this Form 4 were exercised and sold pursuant to a Rule 10b5-1 Sales Plan dated as of December 12, 2018, which is intended to comply with Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended.
  2. This option was granted on March 20, 2015 and is exercisable as the option vests. The option vests over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date.